As of January 2026 Lineage Cell Therapeutics has a market cap of $0.39 Billion USD. This makes Lineage Cell Therapeutics the world's 7584th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 9th, 2026 the market cap of Lineage Cell Therapeutics was reported to be: